This study suggests that miR-183, up-regulated in HCC, represses the expression of the tumor-suppressor PDCD4 posttranscriptionally, and inhibits TGF-β1-induced apoptosis in human HCC cells. The gene discussed is PDCD4; the disease is neoplasm.